Skip to main content

Advertisement

SpringerLink
Log in

Peripheral Delivery of Ganglioside GM1 Exacerbates the Pathogenesis of Alzheimer’s Disease in a Mouse Model

  • Letter to the Editor
  • Published:
Neuroscience Bulletin Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Busche MA, Hyman BT. Synergy between amyloid-β and tau in Alzheimer’s disease. Nat Neurosci 2020, 23: 1183–1193.

    Article  CAS  Google Scholar 

  2. Jiao SS, Yao XQ, Liu YH, Wang QH, Zeng F, Lu JJ. Edaravone alleviates Alzheimer’s disease-type pathologies and cognitive deficits. Proc Natl Acad Sci U S A 2015, 112: 5225–5230.

    Article  CAS  Google Scholar 

  3. Candelise L, Ciccone A. Gangliosides for acute ischaemic stroke. Cochrane Database Syst Rev 2000: CD000094.

  4. Hong S, Ostaszewski BL, Yang T, O’Malley TT, Jin M, Yanagisawa K, et al. Soluble Aβ oligomers are rapidly sequestered from brain ISF in vivo and bind GM1 ganglioside on cellular membranes. Neuron 2014, 82: 308–319.

    Article  CAS  Google Scholar 

  5. Zha Q, Ruan Y, Hartmann T, Beyreuther K, Zhang D. GM1 ganglioside regulates the proteolysis of amyloid precursor protein. Mol Psychiatry 2004, 9: 946–952.

    Article  CAS  Google Scholar 

  6. Matsuoka Y, Saito M, LaFrancois J, Saito M, Gaynor K, Olm V, et al. Novel therapeutic approach for the treatment of Alzheimer’s disease by peripheral administration of agents with an affinity to beta-amyloid. J Neurosci 2003, 23: 29–33.

    Article  CAS  Google Scholar 

  7. Okada T, Wakabayashi M, Ikeda K, Matsuzaki K. Formation of toxic fibrils of Alzheimer’s amyloid beta-protein-(1–40) by monosialoganglioside GM1, a neuronal membrane component. J Mol Biol 2007, 371: 481–489.

    Article  CAS  Google Scholar 

  8. Zhang H, Ding J, Tian W, Wang L, Huang L, Ruan Y, et al. Ganglioside GM1 binding the N-Terminus of amyloid precursor protein. Neurobiol Aging 2009, 30: 1245–1253.

    Article  Google Scholar 

  9. di Biase E, Lunghi G, Maggioni M, Fazzari M, Pomè DY, Loberto N, et al. GM1 oligosaccharide crosses the human blood–brain barrier in vitro by a paracellular route. Int J Mol Sci 2020, 21: 2858.

    Article  CAS  Google Scholar 

  10. Choi BR, Cho WH, Kim J, Lee HJ, Chung C, Jeon WK, et al. Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer’s disease. Exp Mol Med 2014, 46: e75.

    Article  CAS  Google Scholar 

  11. Liu Y, Studzinski C, Beckett T, Guan H, Hersh MA, Murphy MP, et al. Expression of neprilysin in skeletal muscle reduces amyloid burden in a transgenic mouse model of Alzheimer disease. Mol Ther 2009, 17: 1381–1386.

    Article  CAS  Google Scholar 

  12. Guo YL, Duan WJ, Lu DH, Ma XH, Li XX, Li Z, et al. Autophagy-dependent removal of α-synuclein: A novel mechanism of GM1 ganglioside neuroprotection against Parkinson’s disease. Acta Pharmacol Sin 2021, 42: 518–528.

    Article  CAS  Google Scholar 

  13. Kracun I, Kalanj S, Talan-Hranilovic J, Cosovic C. Cortical distribution of gangliosides in Alzheimer’s disease. Neurochem Int 1992, 20: 433–438.

    Article  CAS  Google Scholar 

  14. Ala T, Romero S, Knight F, Feldt K, Frey WH. GM-1 treatment of Alzheimer’s disease. A pilot study of safety and efficacy. JAMA Neurol 1990, 47: 1126–1130.

    CAS  Google Scholar 

  15. Flicker C, Ferris SH, Kalkstein D, Serby M. A double-blind, placebo-controlled crossover study of ganglioside GM1 treatment for Alzheimer’s disease. Am J Psychiatry 1994, 151: 126–129.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Natural Science Foundation of China (81701046) and Chongqing Science and Technology Commission (cstc2018jcyjAX0664).

Author information

Author notes

  1. Chuang-Chuang Yang, Yuan Cheng and Hai-Mei Yang these authors are contributed equally to this work.

Authors and Affiliations

  1. Department of Neurology and Clinical Center for Neuroscience, Daping Hospital, Third Military Medical University, Chongqing, 400042, China

    Chuang-Chuang Yang, Yuan Cheng, Hai-Mei Yang, Yang Chen, Yan-Jiang Wang, Zhi-Qiang Xu & Ye-Ran Wang

Authors
  1. Chuang-Chuang Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuan Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hai-Mei Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yang Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yan-Jiang Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zhi-Qiang Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ye-Ran Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Zhi-Qiang Xu or Ye-Ran Wang.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 1582 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, CC., Cheng, Y., Yang, HM. et al. Peripheral Delivery of Ganglioside GM1 Exacerbates the Pathogenesis of Alzheimer’s Disease in a Mouse Model. Neurosci. Bull. 38, 95–98 (2022). https://doi.org/10.1007/s12264-021-00768-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12264-021-00768-8

Search

Navigation